A practice parameter update and systemic review form the American Academy of Asthma, Allergy and immunology
2017. Management of hereditary angioedema (WAO/EAACI)
World Allergy Organization (WAO) and European Academy of Allergy and Clinical Immunology (EAACI) guidelines on the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2). The key clinical questions covered are: 1) How should HAE be defined and classified?, 2) How should HAE be diagnosed?, 3) Should patients receive prophylactic and/or on-demand treatment and what treatment options should be used?, 4) Should management be different for special patient groups?, 5) Should management incorporate self-administration of therapies?
2017. Sublingual Immunotherapy (AAAAI)
A focused allergen immunotherapy practice parameter update from the American Academy of Asthma, Allergy and Immunology
2017. Diagnosis and management of allergic and non-allergic rhinitis (BSACI)
Updated guidelines for the diagnosis and management of allergic and nonallergic rhinitis produced by the British Society of Allergy and Clinical Immunology.
2015. Guidelines for the Assessment and Management of Anaphylaxis (WAO)
2015 update of guidelines produced by the World Allergy Organisation on anaphylaxis,its assessment, diagnosis and management.
2014. Guidelines for the Management of chronic Rhinosinusitis (WAO)
EAACI, AAAAI, ACAAI and WAO International Consensus (ICON) on Chronic Rhinosinusitis to highlight the key common messages from existing guidelines, the differences in recommendations as well as the gaps in our current knowledge of CRS, thus providing a concise reference.
This clinical practice parameter was developed by the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology (ACAAI) and the
Joint Council of Allergy, Asthma & Immunology (JCAAI).
2014. Drug Allergy: Diagnosis and management (NICE)
The UK National Institute for Health and Clinical Excellence (NICE) guidelines on the diagnosis and management of drug allergy.
2012. Pharmalgen for the treatment of bee and wasp venom allergy (NICE)
The UK National Institute for Health and Clinical Excellence (NICE) recommends Pharmalgen as an option for the treatment of IgE-mediated bee and wasp venom allergy in people who have had a severe systemic reaction to bee or wasp venom or a moderate systemic reaction to bee or wasp venom and who have one or more of the following: a raised baseline serum tryptase, a high risk of future stings or anxiety about future stings. The treatment should be initiated and monitored in a specialist centre experienced in venom immunotherapy.
The UK National Institute for Health and Clinical Excellence (NICE) guideline on Assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode.
The White Book on Allergy produced by the World Allergy Organisation (WAO) covers the practice of allergology, the burden of allergic disease, risk factors and prevention of allergic disease as well as evidence based recommendations for diagnosis and management.
2011. Immunotherapy for Allergic Rhinitis (BSACI)
Allergic rhinitis results in significant morbidity including interfering with both sleep and activities of daily living. These guidelines from the British Society for Allergy and Clinical Immunology (BSACI) are for the management of Allergic Rhinitis in patients that have failed to achieve adequate relief of symptoms despite treatment with intranasal corticosteroids and/or antihistamines.
2011. Diagnosis and management of hymenoptera venom allergy (BSACI)
These evidence based guidelines from the British Society for Allergy and Clinical Immunology (BSACI) are for the management of hymenoptera (bee, wasp, ants) venom allergy and covers epidemiology, risk factors, clinical features, diagnostic tests, natural history and guidance on undertaking venom immunotherapy.
2011.Diagnostic Tools in Rhinology (EAACI)
This guideline from the European Allergy, Asthma and Clinical Immunology (EAACI) society provides a consensus on the diagnosis of nasal and sino-nasal disease covering history taking, clinical examination and additional investigative tools for evaluating the severity of sino-nasal disease.
2011. Food allergy in children and young people (NICE)
The UK National Institute for Health and Clinical Excellence (NICE) guideline on Diagnosis and assessment of food allergy in children and young people inprimary care and community settings
2010. The diagnosis and management of Anaphylaxis (AAAAI)
This practice parameter was developed jointly by the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI) and covers the diagnosis and management of patients with a history of anaphylaxis
2010. Guidelines for the Diagnosis and Management of Food Allergy in the United States (NIAID)
A report of the US National Institute of Allergy and Infectious Diseases (NIAID) Sponsored Expert Panel provides recommendations on how to diagnose and manage food allergy and treat acute food allergy reactions.
This practice parameter was developed jointly by the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI) and covers the diagnosis and management of patients with a history of drug allergy